BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1884374)

  • 1. Oncogene expression and prognosis in cervical cancer.
    Pillai R
    Cancer Lett; 1991 Aug; 59(2):171-5. PubMed ID: 1884374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes and oncoproteins as tumor markers.
    Pillai R
    Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
    Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
    Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
    Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
    Field JK; Spandidos DA
    Anticancer Res; 1990; 10(1):1-22. PubMed ID: 2185684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
    Riou GF
    Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix.
    Sagae S; Kudo R; Kuzumaki N; Hisada T; Mugikura Y; Nihei T; Takeda T; Hashimoto M
    Cancer; 1990 Jul; 66(2):295-301. PubMed ID: 2196111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervico-uterine cancer. Influence of cell and viral genes. Implications in the development of vaccines].
    Gariglio P
    Gac Med Mex; 1998; 134(3):297-307; discussion 309-10. PubMed ID: 9780490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the ras genes in female genital tract cancer.
    Mammas IN; Zafiropoulos A; Spandidos DA
    Int J Oncol; 2005 May; 26(5):1241-55. PubMed ID: 15809715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of prognostic factors in gynecological cancer examined by molecular biological study].
    Nagai N
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1004-9. PubMed ID: 8687214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene diagnosis of uterine cervical cancer].
    Nagai N
    Rinsho Byori; 1994 Apr; 42(4):372-9. PubMed ID: 7909855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of oncogene products as tumour markers.
    Chan S; Sikora K
    Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
    Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
    Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
    Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene expression in cervical cancer.
    Baker VV
    Cancer Treat Res; 1994; 70():43-51. PubMed ID: 8060750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
    Riou GF; Bourhis J; Le MG
    Anticancer Res; 1990; 10(5A):1225-31. PubMed ID: 2173473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of HER-2/neu oncogene in cervical cancer.
    Ndubisi B; Sanz S; Lu L; Podczaski E; Benrubi G; Masood S
    Ann Clin Lab Sci; 1997; 27(6):396-401. PubMed ID: 9433536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and mutation of H-ras in uterine cervical cancer.
    Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
    Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.